<!DOCTYPE html><html lang="en"><head><title>Static News</title><meta charSet="utf-8"/><meta name="description" content="Static delayed Hacker News."/><meta name="theme-color" media="(prefers-color-scheme: light)" content="white"/><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1d1f21"/><meta name="viewport" content="width=device-width,initial-scale=1.0"/><meta name="application-name" content="Static News"/><meta name="apple-mobile-web-app-title" content="Static News"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="#1d1f21"/><link rel="preload" href="styles.css?v=1730451665107" as="style"/><link rel="stylesheet" href="styles.css?v=1730451665107"/></head><body><div id="container"><div id="inner"><header><a href="/">Static News</a><a href="/about">about</a></header><div id="content"><div><div id="title"><a href="https://www.sagelyhealth.com/blog-posts/cancers-magic-bullet-antibody-drug-conjugates">Antibody Drug Conjugates: A frontier in cancer treatment</a> <span class="domain">(<a href="https://www.sagelyhealth.com">www.sagelyhealth.com</a>)</span></div><div class="subtext"><span>peerless-app</span> | <span>23 comments</span></div><br/><div><div id="42012459" class="c"><input type="checkbox" id="c-42012459" checked=""/><div class="controls bullet"><span class="by">Panzer04</span><span>|</span><a href="#42012944">next</a><span>|</span><label class="collapse" for="c-42012459">[-]</label><label class="expand" for="c-42012459">[16 more]</label></div><br/><div class="children"><div class="content">Every little step in fields like this is so encouraging. We keep getting better, but the cancers don&#x27;t.<p>Ever more effective cocktails of drugs that target the cancers while minimising harm to everywhere else, the closer we get to attacking cancer cells from so many different directions they simply can&#x27;t adapt in time and we wipe it out immediately (a cure). One can only hope.<p>I whether we might see even more investment into research like this as it gets closer to deliver curative, rather than just suppressive outcomes, as well</div><br/><div id="42012671" class="c"><input type="checkbox" id="c-42012671" checked=""/><div class="controls bullet"><span class="by">mjewkes</span><span>|</span><a href="#42012459">parent</a><span>|</span><a href="#42012774">next</a><span>|</span><label class="collapse" for="c-42012671">[-]</label><label class="expand" for="c-42012671">[2 more]</label></div><br/><div class="children"><div class="content">CAR-T may have a ~50% cure rate for blood cancers:
<a href="https:&#x2F;&#x2F;ashpublications.org&#x2F;blood&#x2F;article&#x2F;141&#x2F;19&#x2F;2307&#x2F;494672&#x2F;Five-year-follow-up-of-ZUMA-1-supports-the" rel="nofollow">https:&#x2F;&#x2F;ashpublications.org&#x2F;blood&#x2F;article&#x2F;141&#x2F;19&#x2F;2307&#x2F;494672...</a></div><br/><div id="42013721" class="c"><input type="checkbox" id="c-42013721" checked=""/><div class="controls bullet"><span class="by">alexissantos</span><span>|</span><a href="#42012459">root</a><span>|</span><a href="#42012671">parent</a><span>|</span><a href="#42012774">next</a><span>|</span><label class="collapse" for="c-42013721">[-]</label><label class="expand" for="c-42013721">[1 more]</label></div><br/><div class="children"><div class="content">My uncle underwent CAR-T therapy and the turn around was amazing. He&#x27;s got a brand new lease on life. We would have lost him without it.</div><br/></div></div></div></div><div id="42012774" class="c"><input type="checkbox" id="c-42012774" checked=""/><div class="controls bullet"><span class="by">xk_id</span><span>|</span><a href="#42012459">parent</a><span>|</span><a href="#42012671">prev</a><span>|</span><a href="#42012944">next</a><span>|</span><label class="collapse" for="c-42012774">[-]</label><label class="expand" for="c-42012774">[13 more]</label></div><br/><div class="children"><div class="content">&gt; whether we might see even more investment into research<p>The field would benefit greatly from even a fraction of the investment in the AI and crypto bubbles</div><br/></div></div></div></div><div id="42012944" class="c"><input type="checkbox" id="c-42012944" checked=""/><div class="controls bullet"><span class="by">melling</span><span>|</span><a href="#42012459">prev</a><span>|</span><a href="#42013034">next</a><span>|</span><label class="collapse" for="c-42012944">[-]</label><label class="expand" for="c-42012944">[3 more]</label></div><br/><div class="children"><div class="content">Pfizer acquired Seagen for $43 billion. Seagen has some very promising ADC’s in the queue.<p><a href="https:&#x2F;&#x2F;www.pfizer.com&#x2F;news&#x2F;press-release&#x2F;press-release-detail&#x2F;pfizer-completes-acquisition-seagen" rel="nofollow">https:&#x2F;&#x2F;www.pfizer.com&#x2F;news&#x2F;press-release&#x2F;press-release-deta...</a></div><br/><div id="42014417" class="c"><input type="checkbox" id="c-42014417" checked=""/><div class="controls bullet"><span class="by">loeg</span><span>|</span><a href="#42012944">parent</a><span>|</span><a href="#42013266">next</a><span>|</span><label class="collapse" for="c-42014417">[-]</label><label class="expand" for="c-42014417">[1 more]</label></div><br/><div class="children"><div class="content">My dad (retired) spent the back half of his career working on ADCs at Seagen.  He&#x27;s glad ADCs panned out as useful cancer treatments.</div><br/></div></div><div id="42013266" class="c"><input type="checkbox" id="c-42013266" checked=""/><div class="controls bullet"><span class="by">tptacek</span><span>|</span><a href="#42012944">parent</a><span>|</span><a href="#42014417">prev</a><span>|</span><a href="#42013034">next</a><span>|</span><label class="collapse" for="c-42013266">[-]</label><label class="expand" for="c-42013266">[1 more]</label></div><br/><div class="children"><div class="content">It&#x27;s weird to think of a <i>hopeful</i> story of a $43Bn acquisition.</div><br/></div></div></div></div><div id="42013034" class="c"><input type="checkbox" id="c-42013034" checked=""/><div class="controls bullet"><span class="by">namuol</span><span>|</span><a href="#42012944">prev</a><span>|</span><label class="collapse" for="c-42013034">[-]</label><label class="expand" for="c-42013034">[3 more]</label></div><br/><div class="children"><div class="content">&gt; The Food and Drug Administration approves new cancer treatments when they are shown in clinical trials to be more effective than the current approved cancer treatment for a given cancer type. The approval comes when the treatment extends lifespan without overly increasing the risks of serious side effects.<p>This standard just doesn’t make sense to me. Every case is different, so why “throw out” a treatment option for only being within the margin of error of efficacy on a general population? It must be incredibly frustrating for patients to know about these treatments…</div><br/><div id="42015131" class="c"><input type="checkbox" id="c-42015131" checked=""/><div class="controls bullet"><span class="by">howlingowl</span><span>|</span><a href="#42013034">parent</a><span>|</span><a href="#42013125">next</a><span>|</span><label class="collapse" for="c-42015131">[-]</label><label class="expand" for="c-42015131">[1 more]</label></div><br/><div class="children"><div class="content">Never let a customer off the hook too early</div><br/></div></div><div id="42013125" class="c"><input type="checkbox" id="c-42013125" checked=""/><div class="controls bullet"><span class="by">cyberax</span><span>|</span><a href="#42013034">parent</a><span>|</span><a href="#42015131">prev</a><span>|</span><label class="collapse" for="c-42013125">[-]</label><label class="expand" for="c-42013125">[1 more]</label></div><br/><div class="children"><div class="content">It&#x27;s fine to ask for an approval for a part of the population (e.g. people with cancer exhibiting particular markers).</div><br/></div></div></div></div></div></div></div></div></div></body></html>